NCCN Patient Webinar: Thyroid Cancer

1 Views

07/01/23

Experts provide an overview of thyroid cancer and discuss treatment options, side effects, shared decision-making, and more. This webinar is designed for those with thyroid cancer, their caregivers, and their families.

Topics Discussed
2:16 Overview of Thyroid Cancer and Who is Affected
4:13 Types of Thyroid Cancer
6:28 Treatment and Side Effects
9:53 Thyroid Cancer Survivor Survey results
14:03 Impact of Cancer-Related Worry
18:09 Metastatic Thyroid Cancer
20:29 Systemic Therapy and Biomarker Testing
22:13 When Is It Time to Begin Systemic Treatment?
24:00 Metastatic Thyroid Cancer Treatments
25:40 Side Effects of Treatment
29:05 Survivorship
31:38 What is Patient Advocacy?
32:43 Communication in Healthcare
36:51 Advocacy and Access to Care

Question & Answer Session
43:12 After total thyroidectomy, if there are small suspicious lymph nodes, what is the treatment approach?
46:37 What is the life expectancy range for metastatic papillary and metastatic medullary thyroid cancers?
47:29 - With multifocal papillary thyroid cancer, is radioiodine treatment contraindicated in someone with Li-Fraumeni syndrome?
48:44 - How long after surgery can molecular testing be ordered?
49:16 - What are the risks of biopsy and the potential of it to exacerbate spread or metastasis?
50:08 - How long does someone need to be cancer-free after surgery before they are considered cured?
52:32 - Is it common after a thyroidectomy for patients to be diagnosed with high cholesterol and diabetes?
53:23 - What size lymph nodes can be treated with radioiodine therapy?
54:30 - How often have you seen Hürthle cell carcinoma metastasize to the neck?
55:51 - How frequently does cancer change from papillary to a different type of thyroid cancer?
56:59 - Why is fine needle aspiration (FNA) of the thyroid often inconclusive?
58:59 - Is there any indication that papillary thyroid cancer is hereditary?
59:48 - Is there a place for debulking surgery in anaplastic thyroid cancer?
1:00:27 - How do you choose between systemic therapy and clinical trials when a biomarker is found?
101:38 - When a tumor marker has a base level what increase in the level suggests that the cancer could have recurred? Is it normal for these levels to fluctuate small amounts?
103:28 - Can you develop new mutations after your tumor has been genetically tested?
104:39 - How common is lymphedema if lymph nodes are removed, and how quickly after removal would this arise?
105:54 - What's the best way to find out where percutaneous ethanol ablation is available in the United States?
107:33 - How often is medullary thyroid cancer sporadic and not linked to a family history?
108:53 - What are the implications of having papillary and medullary thyroid cancer in an ectopic thyroid nodule?

The Patient Webinar on Thyroid Cancer occurred in August 2022. This informational program was created in conjunction with the recently updated NCCN Guidelines for Patients® for Thyroid Cancer. Access the free patient guidelines: https://www.nccn.org/patientre....sources/patient-reso

The NCCN Guidelines for Patients are available to read and download for free online and via the NCCN Patient Guides for Cancer mobile app. Printed editions can be ordered from Amazon.com for a small fee.

NCCN Guidelines for Patients DO NOT replace the expertise and clinical judgment of the clinician.

Supporters:
This webinar is supported through the NCCN Foundation and by contributions from our corporate supporters: Eisai, Inc.; Exelixis, Inc.; and Lilly.

____________________________________________________________
About NCCN Foundation®:
NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit http://www.nccn.org/patients/foundation
____________________________________________________________
About NCCN:
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.nccn.org/ for more information.

Subscribe to our channel for the latest in cancer care: https://www.youtube.com/c/NCCNvideo?s...

Connect with us!
Twitter: https://twitter.com/NCCN
LinkedIn: https://www.linkedin.com/company/nccn/
Facebook: https://www.facebook.com/NCCNorg
Instagram: https://www.instagram.com/NCCNorg/